DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Garnier M, Boujrad N, Oke BO. et al.
Diazapam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: Action via peripheral-type benzodiazepine receptor and independent mechanisms.
Endocrinology 1993;
132: 444-458
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.